Navigation Links
Low socioeconomic status affects cortisol levels in children over time
Date:1/19/2010

er perceptions of threat and more family chaos, both of which may raise cortisol levels.

This study provides some of the first evidence demonstrating that low SES can alter biological profiles among children in a persistent fashion over time. Taken together, these findings may help explain and provide some first steps toward ameliorating low SES children's vulnerability to mental and physical illnesses in later life. "Health disparities are a pressing reality of our society. To begin to attempt to reduce SES disparities in health, we need to better understand the reasons why they exist," concludes Chen.


'/>"/>

Contact: Catherine Allen-West
cwest@psychologicalscience.org
202-293-9300
Association for Psychological Science
Source:Eurekalert

Page: 1 2

Related biology news :

1. Socioeconomic position associated with effectiveness of HIV drugs
2. First-ever socioeconomic study on coral reefs points to challenges of coastal resource management
3. People of higher socioeconomic status choose better diets -- but pay more per calorie
4. Sequella receives US and EU orphan drug status for SQ109 for the treatment of TB
5. Study identifies trends of vitamin B6 status in US population sample
6. Promptu and OAG Team to Deliver Flight Schedule and Status Information on Mobile Devices
7. U of Minnesota researcher finds link between aggression, status and sex
8. Chemistry professor 1 of only 3 at UH to achieve prestigious AAAS status
9. Hypertension among lower-status employees lingers well into retirement
10. Alert status area in brain discoved by Hebrew University scientists
11. Ambry Genetics Announces Certified Service Provider Status for Agilent Microarrays
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2015)... , Jan. 26, 2015   Epic Sciences , ... cancer, today announced that Murali Prahalad , Ph.D., president ... Medicine World Conference (PMWC) 2015: Silicon Valley, which is ... Mountain View, Calif. on January 26-28, 2015. ... Come of Age as Biomarkers." Last year, Epic Sciences was ...
(Date:2/5/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD and ... focused on the growing mobile commerce market, announces it ... Conference on January 29 th at 10:30 a.m. ... of NXT-ID will present and host a live Q&A ... and its full suite of biometric technologies. Investors can ...
(Date:1/22/2015)... , Jan. 22, 2015 Research and Markets ( ... - A Global Market Overview" report to their offering. ... is to ensure that an individual is who she/he is ... make use of a person,s unique physical characteristics, such as ...
Breaking Biology News(10 mins):Epic Sciences to Present at Personalized Medicine World Conference 2015 on the Use of Circulating Tumor Cells as Cancer Biomarkers 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3Biometrics - A Global Market Overview 2Biometrics - A Global Market Overview 3
... this weeks PLoS Medicine, researchers have found that more ... infectious eye disease trachoma. Six million people most ... the developing world are blind because of the ... that multiple strains of the Chlamydiceae family of bacteria ...
... Hydrogen peroxide, the same mild acid that many people use ... also produced by the body to keep cells healthy. Now, ... how part of this complex process works. Reporting ... by W. Todd Lowther, Ph.D., developed a three-dimensional snapshot of ...
... coalition of 17 organizations, including the National Academy ... the National Science Teachers Association, is calling on ... the promotion of science education, including evolution. According ... issue of The FASEB Journal, the introduction of ...
Cached Biology News:Multiple species of bacteria may cause trachoma: Implications for treatment 2Research explores role of hydrogen peroxide in cell health 2Evolution education is a 'must' says coalition of scientific and teaching organizations 2
(Date:3/4/2015)... 4, 2015 The UPMC Center for Health ... in the Emerging Leaders in Biosecurity Initiative (ELBI). As ... the field of biosecurity, UPMC has selected 28 US ... array of backgrounds, including biological science, medicine, policy, the ... "With the vision and support of the Defense ...
(Date:3/4/2015)... CALGARY , March 4, 2015 /CNW/ ... that it has completed a collaborative research ... quantitative analytics.  Using Fast Collective Evolution Technology ... dataset including all measurements obtained from each ... Company,s Phase 2 clinical trials ASSERT, SUSTAIN ...
(Date:3/4/2015)... , March 4, 2015 Vegalab announced ... in August of last year. As part of the ... Bon Koo continuing his role as CEO for ... of Vegalab S.A., will work alongside Koo and oversee ... - http://photos.prnewswire.com/prnh/20150303/179218 Koo founded ...
(Date:3/3/2015)... 2015 /PRNewswire/ - Aptose Biosciences Inc. (NASDAQ: APTO, TSX: ... diagnostics that target the underlying mechanisms of cancer, today ... ended December 31, 2014. Effective July 17, ... May 31 to December 31. As a result of ... for the quarter and the seven months ended December ...
Breaking Biology Technology:UPMC Center for Health Security Announces 2015 Emerging Leaders in Biosecurity 2UPMC Center for Health Security Announces 2015 Emerging Leaders in Biosecurity 3Resverlogix Collaborates with Emerald Logic to Identify Factors Driving Drug Response and Efficacy in Phase 2 Program 2Resverlogix Collaborates with Emerald Logic to Identify Factors Driving Drug Response and Efficacy in Phase 2 Program 3Resverlogix Collaborates with Emerald Logic to Identify Factors Driving Drug Response and Efficacy in Phase 2 Program 4Korean Government Program Supports Vegalab's Research and Development 2Korean Government Program Supports Vegalab's Research and Development 3Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 2Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 3Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 4Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 5Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 6Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 7Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 8Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 9Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 10Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 11Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 12
... 12 TorreyPines Therapeutics,Inc. (Nasdaq: TPTX ) today ... 2008. For the three-month period, the Company posted,revenue of ... Cash and cash,equivalents totaled $14.3 million at September 30, ... productive as we further,our transition to a development-only company," ...
... CONSHOHOCKEN, Pa., Nov. 12 GEL Interactive,Technologies, a ... Product Director, will be a featured speaker at ... Forum on Defining Appropriate,and Effective Interactions with Thought ... Annual Forum provides a platform for attendees to ...
... Inc.,(Nasdaq: BNVI ) announced today the appointment of ... Weiss is a cardiologist with,expertise in clotting and coagulation ... Institute and the Division of Cardiology at,the University of ... to have Ethan on the scientific advisory board as,we ...
Cached Biology Technology:TorreyPines Therapeutics Reports Third Quarter 2008 Results and Recent Accomplishments 2TorreyPines Therapeutics Reports Third Quarter 2008 Results and Recent Accomplishments 3TorreyPines Therapeutics Reports Third Quarter 2008 Results and Recent Accomplishments 4TorreyPines Therapeutics Reports Third Quarter 2008 Results and Recent Accomplishments 5TorreyPines Therapeutics Reports Third Quarter 2008 Results and Recent Accomplishments 6TorreyPines Therapeutics Reports Third Quarter 2008 Results and Recent Accomplishments 7Cadient Group's GEL Interactive Technologies to Present and Exhibit at CBI's 5th Annual Forum 2Ethan Weiss, M.D., Joins Bionovo's Scientific Advisory Board 2Ethan Weiss, M.D., Joins Bionovo's Scientific Advisory Board 3
... 0-10 psi precision pressure regulator and pressurized ... Faster liquid-switching Steady flow rate ... delivery Can be added to any ... Scientific, any third-party manufacturer, even homemade. Connect to ...
...
Chicken polyclonal to UCK2 ( Abpromise for all tested applications). Antigen: Full length protein, corresponding to amino acids 1-261 of Human UCK2 Entrez Gene ID: 7371 Swiss Protein ID: ...
... (rEK) is a highly purified preparation of ... serine protease which recognizes the identical cleavage ... has similar enzymatic activity. Novagen&'s enzyme is ... purified to yield the highest activity available, ...
Biology Products: